William Lombardi, MD
Interventional Cardiology · Seattle, WANPI 1942250717
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (44.6%), ownership interests and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Asahi Intecc CO., LTD. at 30.4% of the total. Reporting peaked in 2019 at $367,534 and has fallen 97.0% since, to $10,871 in 2025. Among interventional cardiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 501 payments — averaging $1799.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Asahi Intecc CO., LTD.$274K
- Corindus Inc.$239K
- Asahi Intecc USA, Inc.$150K
- Boston Scientific$95K
- Medtronic$53K
- Reflow Medical Inc$23K
- plus $68K from 20 others
Across 20 payments — averaging $5100.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$72K
- Shockwave Medical, Inc$18K
- Abbott$11K
- Asahi Intecc USA, Inc.$1K
Across 4 payments — averaging $52,375 each. An ownership or investment interest held by the physician or an immediate family member.
- Seigla Medical, Inc.$200K
- Verge Medical, Inc.$10K
What the payments were for
- Royalty or licence$402,35945%
- Consulting fees$49,9706%
- Speaking & faculty fees$143,22516%
- Travel & lodging$45,9575%
- Food & beverage$25,5673%
- Ownership interest$234,60926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Asahi Intecc CO., LTD. | 17 | $274,230 |
| Corindus Inc. | 15 | $238,549 |
| Asahi Intecc USA, Inc. | 55 | $149,632 |
| Boston Scientific | 129 | $94,696 |
| Medtronic(2 entities) | 74 | $53,201 |
| Reflow Medical Inc | 7 | $23,484 |
| Siemens Medical Solutions USA, Inc. | 35 | $15,732 |
| Abbott | 57 | $14,577 |
| Vascular Solutions, Inc. | 5 | $12,440 |
| Abiomed | 28 | $7,623 |
| Teleflex LLC | 16 | $5,019 |
| Philips North America LLC | 13 | $4,213 |
| Shockwave Medical, Inc | 23 | $2,705 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $2,000 |
| Arrow International, Inc. | 2 | $1,273 |
| Biosense Webster, Inc. | 1 | $725 |
| Biotronik Inc. | 10 | $675 |
| Celonova Biosciences, Inc. | 1 | $213 |
| Edwards Lifesciences | 1 | $202 |
| W. L. Gore & Associates, Inc. | 1 | $123 |
| Chiesi USA, Inc. | 1 | $107 |
| Avinger Inc. | 1 | $102 |
| Spectrawave, Inc | 2 | $80 |
| Verge Medical, Inc. | 1 | $50 |
| Heartflow, Inc. | 3 | $34 |
| Cardiovascular Systems Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASAHI PTCA Guide Wire ASAHI Gladius Mongo 14$235,032
- ASAHI PTCA Guide Wire$97,899
- ASAHI Corsair Pro XS Microcatheter$47,215
- GENERAL VASCULAR ACCESS$37,277
- CROSSBOSS$29,591
- PERIPHERAL VASCULAR$28,628
- RESOLUTE ONYX$19,929
- Resolute$14,150
- Interventional Products$12,440
- ASAHI Gladius Mongo$11,246
- Watchman$8,000
- CorPath GRX$7,679
- Impella$7,017
- STINGRAY$5,500
- OPTIS$4,626
- GENERAL - THERAPIES$4,489
- Catheter - Turnpike$4,400
- CoreValve Evolut$4,348
- CorPath Imaging System$3,452
- (9520) IGT Devices Undivided$3,250
How this compares
$901,687 in reported general payments places this provider in the 95th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Seattle
- Kathleen KearneySeattle$448K
- Danny DvirSeattle$374K
- James McCabeSeattle$289K
- Christopher BrownSeattle$266K
- Lorenzo AzzaliniSeattle$233K
- Sidakpal PanaichSeattle$214K
- Christine ChungSeattle$210K
- Sameer GafoorSeattle$80K
- Ravi HiraSeattle$64K
- Ming ZhangSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.